Cansativa Distributor of medical cannabis intended to distribute cannabis products from domestic cultivation to various doctors and pharmacies. The company's platform manages every stage of the cannabis value chain from import to distribution and related logistics through an exclusive agreement with Germany's regulatory body to distribute domestically-grown medical cannabis, helping companies to serve thousands of pharmacies across the country.
$15M • 2022 • Series B
Cansativa's platform handles the entire cannabis value chain, managing import, distribution, and associated logistics, all under an exclusive agreement with Germany's regulatory authorities.
Winning pitch decks that have closed millions in investments for leading startups and billion-dollar unicorns.
Investors see 5,000 pitch decks per year. Will you stand out?
No spam. Up to 2 emails/mo – only the good stuff!